Hiscox Ltd Share Price London S.E.
Equities
HSX
BMG4593F1041
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
08/05 | UBS raises Centrica to 'buy' from 'neutral | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.96B 411B | Sales 2025 * | 4.27B 5.44B 451B | Capitalization | 3.95B 5.03B 418B |
---|---|---|---|---|---|
Net income 2024 * | 469M 598M 49.59B | Net income 2025 * | 504M 642M 53.29B | EV / Sales 2024 * | 1.02 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.93 x |
P/E ratio 2024 * |
8.48
x | P/E ratio 2025 * |
7.78
x | Employees | - |
Yield 2024 * |
2.8% | Yield 2025 * |
3.11% | Free-Float | 97.42% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 22/16/22 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 12/22/12 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 16/17/16 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 20/15/20 |
Colin Keogh
BRD | Director/Board Member | 69 | 19/15/19 |
1st Jan change | Capi. | |
---|---|---|
+46.22% | 64.94B | |
+15.19% | 51.49B | |
+12.25% | 48.6B | |
+17.68% | 43.28B | |
+39.05% | 38.12B | |
+72.45% | 32.14B | |
+12.35% | 29.56B | |
+27.20% | 25.51B | |
+2.63% | 21.97B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock